Academic Journal
Q1RMD Open
About RMD Open
RMD Open is a scholarly journal published by BMJ Publishing Group. SCImago 2025 lists it in Q1, with an SJR of 1.798 and H-index of 74.
Coverage: 2015-2026. Research categories: Immunology (Q1); Immunology and Allergy (Q1); Rheumatology (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Rheumatoid Arthritis Research and Therapies; Spondyloarthritis Studies and Treatments; Systemic Lupus Erythematosus Research; Autoimmune and Inflammatory Disorders Research; Systemic Sclerosis and Related Diseases; Psoriasis: Treatment and Pathogenesis.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Early features of cellular ageing impair differentiation capacity in human lymph node fibroblasts prior to rheumatoid arthritis onset
Marina Jiménez-Martínez, Tineke A De Jong, Miranda Houtman, Johanna F Semmelink et al.
2026-10 · DOI: 10.1136/rmdopen-2026-007143Study on the implementation of the 2015 EULAR/ACR recommendations for polymyalgia rheumatica in clinical practice
Michele di Lernia, Konstantin Louis Thuere, Sebastian E Sattui, Kornelis S M van der Geest et al.
2026-10 · DOI: 10.1136/rmdopen-2026-007295Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop)
Christian Dejaco, Irina Gessl, Rusmir Husic, Gregor Mitter et al.
2026-08 · DOI: 10.1136/rmdopen-2026-007003Time to diagnosis in large vessel vasculitis: insights from a retrospective study at a tertiary rheumatology centre
Anna Kernder, Pauline Bussmann, Uta Kiltz, Hilal Kavruk et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006782Associations between synovitis and radiographic osteoarthritis progression in the first carpometacarpal and interphalangeal joints: results from the Nor-Hand study
Lovisa Klingenberg, Ida K Haugen, Hilde Berner Hammer, Øystein Maugesten et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007074Risk of cognitive disorders in patients with primary Sjögren’s disease: data from Korean Health Insurance Service
Hong Ki Min, Seung Won Lee, Sunyeup Kim, Gahyun Kim et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006864Rare variants in genes related to inborn errors of immunity in patients with rheumatoid arthritis and secondary immunodeficiency
Faranaz Atschekzei, Natalia Dubrowinskaja, Manfred Anim, Doris Steinemann et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007046GLP-1 receptor agonists in systemic lupus erythematosus: a scoping review
Robin Sia, Ee Lynn Ting, Suet-Wan Choy, Shereen Oon et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007037Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF: post hoc analysis of SELECT-PsA 2
Laura C Coates, Philip Mease, Arthur Kavanaugh, Joseph F Merola et al.
2026-07 · DOI: 10.1136/rmdopen-2025-006655Whole-blood coagulation and platelet dynamics identify differential prothrombotic states in patients with rheumatoid arthritis treated with JAK or TNF-ɑ inhibitors
Alessandro Giollo, Lorenzo Di Luozzo, Mariangela Salvato, Kiren Khalid et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006960Refining serological scores in rheumatoid arthritis classification: an international study
Lieve Van Hoovels, Christos Chatzichristos, Juan Irure-Ventura, Daphné Vandebeek et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007007Epidemiology of idiopathic inflammatory myopathies: a population-based cohort in England, 2002–2021
Patrick Gordon, Michael McLean, Maciej Czachorowski, Jason Xenakis et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006966Early SLE may follow a fast comorbidity/multimorbidity trajectory associated with flare burden and glucocorticoid exposure
Myrto Nikoloudaki, Sofia Pitsigavdaki, Spyridon Katechis, Ettore Silvagni et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007076Integrating basal and reserve salivary function defines clinically anchored functional phenotypes and contextualises salivary end points in Sjögren’s disease
Chiao-Feng Cheng, Ting-Yuan Lan, Jui-Hung Kao, Tseng-Cheng Chen et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006843Clinical and immunological outcomes of rituximab-based, mycophenolate mofetil-based and cyclophosphamide-based treatment strategies for systemic lupus erythematosus with active kidney involvement from LOOPS registry
Masanobu Ueno, Ippei Miyagawa, Hiroaki Tanaka, Satoshi Kubo et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007370Real-world efficacy and safety of avacopan in ANCA-associated vasculitis: a retrospective comparative study
Franz Thiele, Johanna Schneider, Eric Prager, Ilona Jandova et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006792Predicting disease flares in axial spondyloarthritis using different machine learning models in the METEOR-SpA registry
Benavent D, Fanjul V, Bergstra S A, van Gaalen F et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007147SIK inhibitor HG-9-91-01 suppresses the pathogenic activity of fibroblast-like synoviocytes in rheumatoid arthritis
Xiaohao Wang, Yuanyuan Li, Hanchao Li, Lingfei Mo et al.
2026-07 · DOI: 10.1136/rmdopen-2026-007000Risk of cancer induced by human papillomavirus in patients with immune-mediated inflammatory diseases: a nationwide matched cohort study
Clothilde Gros, Tiphaine Goulenok, Jean-François Timsit, Karim Sacre et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006927Beyond genotype: clustering analysis highlights clinical heterogeneity in paediatric familial Mediterranean fever
Isild Mahé, Claire Billard, Federica Anselmi, Linda Rossi-Semerano et al.
2026-07 · DOI: 10.1136/rmdopen-2026-006764Reviews
Community Reviews
Version History
September 25, 2026 at 7:13 am
September 25, 2026